CO16 Assessing the Real-World Impact of Earlier Initiation of Anti-Tumor Necrosis Factor vs. Conventional Synthetic DMARDs on Clinical and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis in Europe
Abstract
Authors
Daniel Aletaha Carmen Bremer Jack Milligan Ethan Cao Rachael Meadows Xenofon Baraliakos